at 7867

AT7867 dihydrochloride 是一种有效的ATP 竞争性的Akt1/Akt2/Akt3和p70S6K/PKA 抑制剂，IC50值分别为 32 nM/17 nM/47 nM 和 85 nM/20 nM，具有癌症治疗的潜力。

AT7867 是 ATP 竞争性的Akt1/Akt2/Akt3和p70S6K/PKA 抑制剂，IC50分别为 32、17、47 和 85、20 nM。

AT7867 hydrochloride是一种针对AKT和p70 S6 kinase的强效、具有口服活性的抑制剂，展现出抗肿瘤效果。

DA-7867 is a novel oxazolidinone. DA-7867 had the lowest MIC for 90% of the aerobic gram-positive bacterial strains tested (≤0.25 μg/ml) and it was more potent than linezolid. DA-7867 was the most active drug with a MIC(90) of 0.125 μg/ml.